Prosecution Insights
Last updated: August 17, 2026

Examiner: BABSON, NICOLE PLOURDE

Tech Center 1600 • Art Units: 1612 1616 1619

This examiner grants 46% of resolved cases

Performance Statistics

46.5%
Allow Rate
-13.5% vs TC avg
588
Total Applications
+33.1%
Interview Lift
1299
Avg Prosecution Days
Based on 531 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
12.7%
§102 Novelty
48.6%
§103 Obviousness
22.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18541516 CLEAR SCALP COMPOSITION WITH DISCRETE PARTICLES Final Rejection The Procter & Gamble Company
17078781 PERSONAL CARE COMPOSITION PRESERVATIVES LEVEL OPTIMIZATION Non-Final OA The Procter & Gamble Company
17437370 MONOCYTE-SELECTIVE DRUG DELIVERY SYSTEM USING SINGLE-WALLED CARBON NANOTUBES TO INDUCE EFFEROCYTOSIS Final Rejection The Board of Trustees of the Leland Stanford Junior University
18567495 COMPOSITION FOR MAKE-UP USE, COMPRISING FLAKE-TYPE ALUMINUM PIGMENTS AND FLAKE-TYPE BLACK PIGMENTS Final Rejection L'OREAL
18374859 NAIL POLISH TOPCOAT COMPOSITION Final Rejection L'OREAL
18231729 COMPOSITIONS AND METHODS FOR TREATING KERATIN FIBERS Final Rejection L'Oreal
18258426 INVERSE EMULSION COMPRISING ETHYL CELLULOSE, AN ETHER OR CARBONATE HYDROCARBON-BASED OIL AND METHOD EMPLOYING SAME Final Rejection L'OREAL
17537553 OPTICALLY-TRANSFORMING NAIL COATINGS, METHODS, AND SYSTEMS Final Rejection L'OREAL
17151558 COMPOSITIONS AND METHODS FOR HAIR Non-Final OA L'OREAL
18883730 ORALLY DISINTEGRATING NICOTINE TABLET WITH LOW AMOUNT OF FLAVOR Non-Final OA Fertin Pharma A/S

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month